PerformSpecialty Receives URAC Rare Disease Pharmacy Designation and Specialty Pharmacy Accreditation
November 11, 2021 - Orlando, Fl.
Orlando, Fl. – PerformSpecialty, LLC, a full-service specialty pharmacy owned by PerformRxSM and part of the AmeriHealth CaritasSM Family of Companies, announced today that, in addition to its third consecutive URAC Specialty Pharmacy Accreditation, it has earned URAC’s Rare Disease Center of Excellence Designation. URAC, a Washington, D.C.-based health care accrediting organization, establishes quality standards for the health care industry.
URAC’s Rare Disease Center of Excellence Designation signifies PerformSpecialty’s commitment to high-quality pharmacy practice and advanced expertise in rare disease treatment. URAC’s Specialty Pharmacy Accreditation is validation of the company’s excellence in specialty pharmacy management, as well its continuous quality improvements that result in better operations and compliance outcomes.
“Helping people get the advanced care they need for conditions that are complex and uncommon is what drew me to specialty pharmacy early in my career,” said PerformSpecialty Executive Director, Dino Martino, R.Ph. “Earning the Rare Disease Center of Excellence Designation is a distinguished honor. Our focus is to be a resource for those struggling to find answers and options when extraordinary health conditions enter peoples’ lives.”
PerformSpecialty provides complete pharmaceutical care management driven by clinical expertise and an unyielding commitment to patients. PerformSpecialty’s goal is to keep patients actively engaged in their treatment to improve their overall health and well-being. With URAC’s Rare Disease Pharmacy Designation, PerformSpecialty demonstrates to its patients, manufacturers, and providers its continued commitment to attain and maintain the highest level of standards.
“It’s necessary for specialty pharmacies to provide a higher level of treatment for patients so desired outcomes are achieved. PerformSpecialty shows a dedication to patient education and safety through the recognition of quality it received with URAC’s independent accreditation,” said URAC President and CEO Shawn Griffin, M.D. “With URAC accreditation, people know that PerformSpecialty strives to adhere to industry best practices. By achieving URAC’s specialty pharmacy accreditation and a rare disease designation, PerformSpecialty has demonstrated excellence in quality care delivery and their long-term commitment to ensuring patient safety and improving outcomes.”
Founded in 1990 as a non-profit organization, URAC is the independent leader in promoting health care quality and patient safety through renowned accreditation programs. URAC develops its evidence-based standards in collaboration with a wide array of stakeholders and industry experts. The company’s portfolio of accreditation and certification programs span the health care industry, addressing health care management and operations, pharmacies, telehealth, health plans, medical practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.